Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Isolation of a new polyoxometalate complex of plutonium

Ian Colliard a, Vitalie Stavila b and Gauthier J.-P. Deblonde *a
aLawrence Livermore National Laboratory, Livermore, CA 94550, USA. E-mail: Deblonde1@LLNL.gov
bSandia National Laboratories, Livermore, CA 94551, USA

Received 19th June 2025 , Accepted 3rd July 2025

First published on 3rd July 2025


Abstract

We report the synthesis, plus structural and spectroscopic characterization, of a plutonium(IV) complex with the polyoxometalate W5O186−. The complex was isolated as Cs8[Pu(W5O18)2]·CsCl·6.5H2O, with the tetravalent actinide cation sandwiched between two lacunary polyoxotungstate anions. It represents a rare case of a POM compound with plutonium and also the first Peacock–Weakley type complex of plutonium.


Thus far, a few hundred plutonium (Pu) compounds have been synthesized and characterized, encompassing different categories of materials, from metallic phases and oxides1,2 to complexes with organic ligands,3–5 inorganic compounds,6–10 MOFs,11,12 oxo/hydroxo-clusters,13,14 and more. However, only a small number of Pu complexes with polyoxometalates (POM) are currently known. In fact, only two crystal structures of POM complexes with the Pu4+ ion15,16 and two crystal structures with the PuO22+ ion17,18 have been published to date.

Sokolova et al.15 reported in 2009 the first successful synthesis and structural characterization of a complex of Pu4+ with a POM ligand. The authors obtained K12H4Pu(P2W17O61)2·19H2O, which consists of two P2W17O6110− ligands bound to one Pu4+ ion. This complex belongs to the Wells–Dawson POM category. In 2016, Charushnikova et al.16 expanded the chemistry of Pu–POM to polyoxomolybdates, with the structural characterization of Pu4+ encapsulated in Mo12O4212−, which belongs to the Dexter-Silverton POM category. Another major category of POMs19 is the Peacock–Weakley complexes20 which typically features one cation coordinated to two W5O186− (W5) ligands (Fig. 1). However, despite the large body of literature on W5 and on Pu chemistries, no plutonium compound with this type of POM has been reported yet.


image file: d5cc03481g-f1.tif
Fig. 1 Reaction scheme and equation for forming the water-soluble plutonium(IV) complex with the POM ligand W5O186−, formulated [Pu(W5O18)2]8−. The complex was isolated in the solid-state as Cs8[Pu(W5O18)2]·CsCl·6.5H2O.

The W5 anion has been has the subject of numerous studies due to its ability to complex a wide range of cations in aqueous and non-aqueous media, as well as the versatility of the compounds for a broad range of applications. For example, the W5 complexes with lanthanides can be used as tuneable luminescent materials.21 The magnetic properties of W5 compounds have also been the subject of many experimental and theoretical studies.22,23 Some lanthanide–W5 complexes function as molecular nanomagnets with long coherence times, and have been proposed for quantum applications.24,25

In terms of tetravalent cations, the W5 complexes with Zr4+, Ce4+, Th4+, U4+, and Np4+ have been crystallized and their structures determined. Na8[U(W5O18)2]·30H2O was first reported by Golubev et al.26 in 1975, Na8[Ce(W5O18)2]·31H2O by Rosu & Weakley27 in 1998, Na8[Th(W5O18)2]·28H2O by Griffith et al.28 in 2000, (Me4N)2[ZrW5O18(H2O)2(DMSO)] by Carabineiro et al.29 in 2006, K4Na3H[Np(W5O18)2]·16H2O by Villars et al.30 in 2012. We note that none of the protocols used in these prior studies would be directly transposable to plutonium chemistry due to the large amounts of materials required, with tens to hundreds of milligrams of the target element engaged in the reactions (Table S1, ESI).

Herein, we describe efforts to overcome the radiolytic constraints associated with plutonium isotopes by leveraging a microscale technique that we previously used for other actinide–POM systems,31–34 and completed the series of tetravalent W5 complexes. Using only 3.4 micrograms of weapons-grade Pu (Fig. 1 and Table S1, ESI), we managed to crystalize the compound as its caesium salt, Cs8[Pu(W5O18)2]·CsCl·6.5H2O (Cs8Pu(W5)2).

Cs8Pu(W5)2 was prepared by adding 1 eq. of Pu4+ to an aqueous solution containing ∼50 eq. of sodium tungstate (Na2WO4) and buffered at pH 6 by 0.5 M sodium acetate. At the pH of the reaction, the WO42− anions are unstable and readily undergo hydrolysis and condensation to form POMs. In the absence of cations, non-lacunary paratungstate salts can be obtained. In the presence of cations, like Pu4+, the speciation is driven towards the complexation of the cation by W5 anions, resulting in a 1[thin space (1/6-em)]:[thin space (1/6-em)]2 complex, [Pu(W5O18)]8−. With subsequent addition of excess counterions (e.g., alkali), the W5 complexes often precipitate or, under suitable conditions, crystallize. Upon addition of excess Cs+ ions (Cs[thin space (1/6-em)]:[thin space (1/6-em)]W5[thin space (1/6-em)]:[thin space (1/6-em)]Pu ratio 1.3 × 105[thin space (1/6-em)]:[thin space (1/6-em)]10[thin space (1/6-em)]:[thin space (1/6-em)]1), several crystals of Cs8Pu(W5)2 were obtained (Fig. 1 and Fig. S1, ESI). Due to the small scale of the reaction and low Pu and W5 concentrations (i.e., [Pu]initial = 24 μM, [W5]initial = 240 μM), the Cs8Pu(W5)2 crystals only appeared after about 3 months, and no by-product was co-crystallized. The synthesis was done at room temperature, in water, was one-pot, and without any complex steps like filtrations that can be detrimental to experiments with Pu.

For other elements, the obtention of some XRD-quality crystals can often be solved by scaling-up the synthesis to several milligrams of more (Table S1, ESI). In the case of Pu, this kind of approach cannot be used due to its radiotoxicity. Even at the milligram scale, reactions with Pu represent a significant radiological hazard, plus logistical and financial burden. Syntheses at this scale can also result in radiolytic damage to the compound, so that scientists often resort to using longer-lived isotopes, i.e., 242Pu or 244Pu (Half-lives = 3.73 × 105 and 8.13 × 107 years, respectively), which are only made in minute quantities for research and are highly expensive. We overcame these issues by minimizing the reaction scale, down to a few micrograms of the target element. The small scale allowed us to directly use weapons-grade Pu (i.e., 94% 239Pu, 6% 240Pu, see ESI for details), an isotope mixture that is less costly to produce and isolate than research-grade 242Pu or 244Pu. The reaction was done with 3.4 μg of WGPu, corresponding to 8.6 kBq (or 233 nCi). At this scale, the use of 238Pu (Half-life = 87.7 years), which is another Pu isotope that is easier to produce than 242Pu or 244Pu, could also be considered knowing that 3 μg of 238Pu corresponds to ∼1.9 MBq (∼50 μCi), which is still a manageable activity level. In future studies, we will leverage our microscale POM synthesis to probe isotopic effects on the properties of actinide coordination compounds.

The crystals obtained were first analyzed via Raman microscopy. Fig. 2 shows the solid-state spectrum of the compound. The Raman features confirmed that the crystal contained a W5 complex. The Raman spectrum of Cs8Pu(W5)2 is readily different from that of its starting material (Na2WO4·2H2O, Fig. S2, ESI). The Raman peaks pattern for Cs8Pu(W5)2 is consistent with that of Na8[Th(W5O18)2]·28H2O, Na8[Ce(W5O18)2]·31H2O and Cs8[U(W5O18)2]·12H2O previously reported.28,35,36 By analogy to an experimental and TD-DFT study performed on the equivalent complex with Ce4+ by Roy et al.,36 the features in the 950–1000 cm−1 region are characteristic of terminal ν(W = Ot) stretching modes, the bands at 500–850 cm−1 correspond to bridging ν(W–O–W) and ν(W–O–Pu) stretches. The multiple bands around 400 cm−1 correspond to the bending, rocking, and twisting modes of the complex, while the lower energy bands around 200 cm−1 represent Pu–O stretches.36


image file: d5cc03481g-f2.tif
Fig. 2 Solid-state Raman spectrum of the plutonium(IV) complex with the POM ligand W5O186− (purple), and background from the sample holder (grey).

Crystals of the sample were also analysed by solid-state UV-visible absorbance microspectrophotometry. As the crystal obtained were thin plates, their absorbance was relatively faint, but they appeared slightly red-orange under an optical microscope (Fig. 3a). This colour is often a characteristic of Pu4+ compounds.1,37 The UV-visible spectrum confirmed the presence of Pu4+ in the compound, with no sign of other oxidation states of Pu. The Cs8Pu(W5)2 crystals exhibit main absorbance bands at 459, 472, 519, and 650 nm (Fig. 3b). These bands are consistent with the characteristic absorbance features observed for our reference solution of Pu4+ (Fig. S3, ESI) and other reference spectra for the +IV oxidation state of Pu.1,38 As expected, the ligand field of the two POM ligands induces some minor shifts relative to aqueous Pu(IV). Similar shifts have been reported for Pu4+ complexes with donating oxygens, such as oxalates,39 peroxides,9 or organic ligands.3


image file: d5cc03481g-f3.tif
Fig. 3 Solid-state absorbance spectrum of the plutonium(IV) complex with the POM W5O186−. (a) Raw spectrum. Inset: A cluster of crystals used for the analysis. (b) Baseline subtracted spectrum, highlighting the transitions that correspond to Pu4+.

Single crystal XRD analysis definitively confirmed the isolation of a new POM complex containing Pu4+. The isolated compound follows the same general speciation as the previous cases with other tetravalent metals,26–28,30,35 with formation of 1[thin space (1/6-em)]:[thin space (1/6-em)]2 species, i.e., [Pu(W5O18)]8−. The obtained compound is fully formulated as Cs8[Pu(W5O18)2]·CsCl·6.5H2O. It crystallizes in anorthic space group P[1 with combining macron], with a cell volume of 5056.8(1) A3 (see Table S2 for full crystallographic details, ESI). The asymmetric unit that describes half the unit cell is comprised of two unique [Pu(W5O18)2]8− complexes (Fig. 4). Cs+ counterions then connect the [Pu(W5O18)2]8− units together creating an extended three-dimensional network. Excess solvent water molecules and chloride ions can also be found connected throughout the Cs–Pu–W5 network (Fig. S4–S6, ESI).


image file: d5cc03481g-f4.tif
Fig. 4 Structure of the Cs8Pu(W5)2 compound showing (a) polyhedral representation of the core complex [Pu(W5O18)2]8−; (b) polyhedral representation with Cs, Cl, and solvent waters surrounding the asymmetric unit, and (c) top-down view showing only the equatorial Cs+ counterions and their proximity to the Pu4+ cation. Colour code: Pu in blue, W in marron, Cs in cyan, Cl in green, O in red.

As illustrated in Fig. 4, the Cs+ counterions are tightly packed around the Pu–POM complex. Indeed, each unique [Pu(W5O18)2]8− has five Cs+ located around the equatorial plane of the complex, at 4.35–4.67 Å away from Pu4+, plus a sixth one from the neighbouring complex, with Cs–Pu distance of ∼6.7 Å (Fig. 4c). These are remarkably short distances for two cations in aqueous environment. No such interaction is seen in the previous structures reported for tetravalent complexes of W5 (Table S1, ESI). The positions of Cs+ in Cs8Pu(W5)2 contrast sharply with all the equivalent structures with Th4+, U4+, or Np4+ and W5 previously reported.26,28,35 In a recent study from Subintoro and Carter,35 the authors found alkali-U distances of 5.8–7.2 Å in Ax[U(W5O18)2nH2O, regardless of the alkali counterion (A = Li, Na, K, Rb, or Cs)—a difference of 1.5–2.5 Å compared to Cs8Pu(W5)2. Interestingly, we previously observed32 a somewhat similar interaction between multiple Cs+ counterions and the analogous complex with trivalent curium ([Cm(W5O18)2]9−), with Cm–Cs distances of 4.48–4.54 Å. This hints that the interactions between counterions, the two POM ligands, and the central f-element maybe be specific in the case of Pu4+ and Cm3+, with an outsized impact of the Cs+ counterions on the overall structure. Efforts are on-going to expand the experimental dataset on transuranic–POM complexes and to rationalize these seemingly transuranic-specific effects via computation.

The average Pu–O bond distance in Cs8Pu(W5)2 is 2.378 Å, which is consistent with the oxidation state +IV of Pu. However as shown in Fig. S7 and Table S3 (ESI), this is slightly longer than what would be extrapolated from the related complexes with Zr4+, Th4+, U4+, and Np4+. It appears that the tightly packed Cs+ counterions in the equatorial plane of the complex lead to a slight elongation of the Pu–O bonds. Bond Valence Summation calculations reveal a calculated valency of 3.6 valence units, which is consistent with the slightly longer bond lengths measured for Pu–O resulting in a underbonded Pu(IV). If the Cs counterions are positioned close to Pu4+, in the equatorial plane, then we presume that the structure compensates with a slight bond elongation along the perpendicular axis (i.e., stretching the complex along its long axis – Fig. 4).

In conclusion, our microscale synthesis approach allowed for the extension of the chemistry of W5 POM to plutonium, providing an important step toward better understanding actinide coordination requirements and informing ongoing efforts to develop novel actinide-based materials. The isolated compound, Cs8[Pu(W5O18)2]·CsCl·6.5H2O, is the first Pu complex of the Peacock–Weakley category. The structure features elongated Pu–O bonds and closely packed Cs+ counterions around the complex, which is different from the complexes of W5 with other tetravalent cations but reminiscent of what is observed for the analogous compound with trivalent curium. Work is underway to extend this chemistry to other cation-POM-counterions systems.

This material is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Heavy Element Chemistry program at Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. Sandia National Laboratories is a multimission laboratory managed and operated by National Technology & Engineering Solutions of Sandia, LLC, a wholly owned subsidiary of Honeywell International Inc., for the U.S. Department of Energy's National Nuclear Security Administration (DOE/NNSA) under Contract DE-NA0003525. Release number: LLNL-JRNL-2007860.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data supporting this article has been included as part of the ESI. Crystallographic data for the plutonium compound has been deposited at the CCDC (Deposition number 2465152).

References

  1. D. L. Clark, S. S. Hecker, G. D. Jarvinen and M. P. Neu, in The Chemistry of the Actinide and Transactinide Elements, ed. L. R. Morss, N. M. Edelstein and J. Fuger, Springer, Netherlands, Dordrecht, 2011, pp. 813–1264 Search PubMed.
  2. H. Yasuoka, G. Koutroulakis, H. Chudo, S. Richmond, D. K. Veirs, A. I. Smith, E. D. Bauer, J. D. Thompson, G. D. Jarvinen and D. L. Clark, Science, 2012, 336, 901–904 CrossRef CAS PubMed.
  3. S. K. Cary, S. S. Galley, M. L. Marsh, D. L. Hobart, R. E. Baumbach, J. N. Cross, J. T. Stritzinger, M. J. Polinski, L. Maron and T. E. Albrecht-Schmitt, Nat. Chem., 2017, 9, 856–861 CrossRef CAS PubMed.
  4. C. J. Windorff, G. P. Chen, J. N. Cross, W. J. Evans, F. Furche, A. J. Gaunt, M. T. Janicke, S. A. Kozimor and B. L. Scott, J. Am. Chem. Soc., 2017, 139, 3970–3973 CrossRef CAS PubMed.
  5. C. J. Windorff, C. A. P. Goodwin, J. M. Sperling, T. E. Albrecht-Schönzart, Z. Bai, W. J. Evans, Z. K. Huffman, R. Jeannin, B. N. Long, D. P. Mills, T. N. Poe and J. W. Ziller, Inorg. Chem., 2023, 62, 18136–18149 CrossRef CAS PubMed.
  6. S. Wang, E. V. Alekseev, J. Ling, S. Skanthakumar, L. Soderholm, W. Depmeier and T. E. Albrecht-Schmitt, Angew. Chem., Int. Ed., 2010, 49, 1263–1266 CrossRef CAS PubMed.
  7. S. Wang, E. V. Alekseev, W. Depmeier and T. E. Albrecht-Schmitt, Inorg. Chem., 2011, 50, 2079–2081 CrossRef CAS PubMed.
  8. R. E. Wilson, P. M. Almond, P. C. Burns and L. Soderholm, Inorg. Chem., 2006, 45, 8483–8485 CrossRef CAS PubMed.
  9. J. Margate, S. Bayle, T. Dumas, E. Dalodière, C. Tamain, D. Menut, P. Estevenon, P. Moisy, S. I. Nikitenko and M. Virot, Chem. Commun., 2024, 60, 6260–6263 RSC.
  10. K. O. Kvashnina, A. Y. Romanchuk, I. Pidchenko, L. Amidani, E. Gerber, A. Trigub, A. Rossberg, S. Weiss, K. Popa, O. Walter, R. Caciuffo, A. C. Scheinost, S. M. Butorin and S. N. Kalmykov, Angew. Chem., Int. Ed., 2019, 58, 17558–17562 CrossRef CAS.
  11. A. M. Hastings, D. Ray, W. Jeong, L. Gagliardi, O. K. Farha and A. E. Hixon, J. Am. Chem. Soc., 2020, 142, 9363–9371 CrossRef CAS PubMed.
  12. K. Lv, C. Urbank, M. Patzschke, J. März, P. Kaden, S. Weiss and M. Schmidt, J. Am. Chem. Soc., 2022, 144, 2879–2884 CrossRef CAS PubMed.
  13. M. Cot-Auriol, M. Virot, T. Dumas, O. Diat, D. Menut, P. Moisy and S. I. Nikitenko, Chem. Commun., 2022, 58, 13147–13150 RSC.
  14. M. Virot, T. Dumas, M. Cot-Auriol, P. Moisy and S. I. Nikitenko, Nanoscale Adv., 2022, 4, 4938–4971 RSC.
  15. M. N. Sokolova, A. M. Fedosseev, G. B. Andreev, N. A. Budantseva, A. B. Yusov and P. Moisy, Inorg. Chem., 2009, 48, 9185–9190 CrossRef CAS PubMed.
  16. I. A. Charushnikova, A. V. Gogolev, M. S. Grigor’ev and A. M. Fedoseev, Radiochemistry, 2016, 58, 457–465 CrossRef CAS.
  17. R. Copping, C. Talbot-Eeckelaers, D. Collison, M. Helliwell, A. J. Gaunt, I. May, S. D. Reilly, B. L. Scott, R. D. McDonald, O. A. Valenzula, C. J. Jones and M. J. Sarsfield, Dalton Trans., 2009, 5609–5611 RSC.
  18. H. Zhang, A. Li, K. Li, Z. Wang, X. Xu, Y. Wang, M. V. Sheridan, H.-S. Hu, C. Xu, E. V. Alekseev, Z. Zhang, P. Yan, K. Cao, Z. Chai, T. E. Albrecht-Schönzart and S. Wang, Nature, 2023, 616, 482–487 CrossRef CAS PubMed.
  19. M. Nyman and P. C. Burns, Chem. Soc. Rev., 2012, 41, 7354–7367 RSC.
  20. R. D. Peacock and T. J. R. Weakley, J. Chem. Soc. A, 1971, 1836–1839 RSC.
  21. H. Zhang, X. Li, L. Zhang, Y. Zhou, X. Ren and M. Liu, J. Alloys Compd., 2018, 749, 229–235 CrossRef CAS.
  22. M. A. AlDamen, S. Cardona-Serra, J. M. Clemente-Juan, E. Coronado, A. Gaita-Ariño, C. Martí-Gastaldo, F. Luis and O. Montero, Inorg. Chem., 2009, 48, 3467–3479 CrossRef CAS PubMed.
  23. A. Gaita-Ariño, F. Luis, S. Hill and E. Coronado, Nat. Chem., 2019, 11, 301–309 CrossRef PubMed.
  24. M. Shiddiq, D. Komijani, Y. Duan, A. Gaita-Ariño, E. Coronado and S. Hill, Nature, 2016, 531, 348–351 CrossRef CAS PubMed.
  25. S. G. McAdams, A.-M. Ariciu, A. K. Kostopoulos, J. P. S. Walsh and F. Tuna, Coord. Chem. Rev., 2017, 346, 216–239 CrossRef CAS.
  26. A. M. Golubev, L. P. Kazanskij, E. A. Torchenkova, V. I. Simonov and V. I. Spitsyn, Dokl. Akad. Nauk SSSR, 1975, 221, 351–352 CAS.
  27. C. Rosu and T. J. R. Weakley, Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 1998, 54, IUC9800047 CrossRef.
  28. W. P. Griffith, N. Morley-Smith, H. I. S. Nogueira, A. G. F. Shoair, M. Suriaatmaja, A. J. P. White and D. J. Williams, J. Organomet. Chem., 2000, 607, 146–155 CrossRef CAS.
  29. H. Carabineiro, R. Villanneau, X. Carrier, P. Herson, F. Lemos, F. Ramôa Ribeiro, A. Proust and M. Che, Inorg. Chem., 2006, 45, 1915–1923 CrossRef CAS PubMed.
  30. P. Villars, K. Cenzual, R. Gladyshevskii, O. Shcherban, V. Dubenskyy, V. Kuprysyuk, I. Savysyuk and R. Zaremba, in Structure Types. Part 11: Space groups (135) P42/mbc–(123) P4/mmm, ed. P. Villars and K. Cenzual, Springer Berlin Heidelberg, Berlin, Heidelberg, 2012, vol. 43A11, pp. 213–214 Search PubMed.
  31. I. Colliard, J. R. I. Lee, C. A. Colla, H. E. Mason, A. M. Sawvel, M. Zavarin, M. Nyman and G. J.-P. Deblonde, Nat. Chem., 2022, 14, 1357–1366 CrossRef CAS PubMed.
  32. I. Colliard and G. J.-P. Deblonde, Chem. Commun., 2024, 60, 5999–6002 RSC.
  33. I. Colliard and G. J.-P. Deblonde, JACS Au, 2024, 4, 2503–2513 CrossRef CAS PubMed.
  34. I. Colliard and G. J.-P. Deblonde, J. Am. Chem. Soc., 2025, 147, 14455–14467 CrossRef CAS PubMed.
  35. P. J. Subintoro and K. P. Carter, Inorg. Chem., 2025, 64, 11380–11397 CrossRef CAS PubMed.
  36. L. E. Roy, D. Ortiz-Acosta, E. R. Batista, B. L. Scott, M. W. Blair, I. May, R. E. D. Sesto and R. L. Martin, Chem. Commun., 2010, 46, 1848–1850 RSC.
  37. R. E. Wilson, Inorg. Chem., 2011, 50, 5663–5670 CrossRef CAS PubMed.
  38. D. Cohen, J. Inorg. Nucl. Chem., 1961, 18, 211–218 CrossRef CAS.
  39. A. K. Sockwell, T. F. M. Sweet, B. Barth, P. C. Burns and A. E. Hixon, Inorg. Chem., 2024, 63, 56–60 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available. CCDC 2465152. For ESI and crystallographic data in CIF or other electronic format see DOI: https://doi.org/10.1039/d5cc03481g

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.